Beryl Drugs Limited (BOM:524606)
India · Delayed Price · Currency is INR 21.72
-0.28 (-1.27%)
At close: Jul 28, 2026
Beryl Drugs Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 110 | 98 | 107 | 149 | 62 | 53 | |
Market Cap Growth | 4.42% | -8.41% | -28.23% | 141.20% | 16.36% | 58.09% |
Enterprise Value | 132 | 140 | 150 | 194 | 106 | 85 |
Last Close Price | 21.72 | 19.28 | 21.05 | 29.33 | 12.16 | 10.45 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 25.86 | 23.02 | 18.45 | 19.35 | 8.05 | - |
PS Ratio | 0.59 | 0.52 | 0.51 | 0.56 | 0.23 | 0.36 |
PB Ratio | 1.11 | 0.99 | 1.12 | 1.67 | 0.77 | 0.73 |
P/TBV Ratio | 1.11 | 0.99 | 1.12 | 1.67 | 0.77 | 0.73 |
P/FCF Ratio | - | - | 23.65 | - | 7.45 | - |
P/OCF Ratio | 3.02 | 2.68 | 4.05 | 18.14 | 2.58 | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 0.70 | 0.75 | 0.71 | 0.73 | 0.40 | 0.58 |
EV/EBITDA Ratio | 5.44 | 5.78 | 5.73 | 7.34 | 4.77 | 15.35 |
EV/EBIT Ratio | 14.14 | 15.03 | 10.91 | 13.43 | 7.52 | - |
EV/FCF Ratio | - | - | 33.29 | - | 12.81 | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.25 | 0.25 | 0.43 | 0.57 | 0.56 | 0.73 |
Debt / EBITDA Ratio | 1.01 | 1.01 | 1.56 | 1.93 | 2.04 | 9.60 |
Debt / FCF Ratio | - | - | 9.08 | - | 5.49 | - |
Net Debt / Equity Ratio | 0.22 | 0.22 | 0.35 | 0.56 | 0.49 | 0.63 |
Net Debt / EBITDA Ratio | 0.89 | 0.89 | 1.25 | 1.88 | 1.78 | 8.38 |
Net Debt / FCF Ratio | -12.41 | -12.41 | 7.28 | -9.35 | 4.80 | -5.23 |
Asset Turnover | 1.22 | 1.22 | 1.26 | 1.53 | 1.52 | 0.80 |
Inventory Turnover | 3.63 | 3.63 | 5.73 | 9.72 | 7.24 | 3.27 |
Quick Ratio | 0.53 | 0.53 | 1.47 | 1.34 | 1.25 | 0.79 |
Current Ratio | 1.52 | 1.52 | 2.10 | 1.76 | 1.64 | 1.24 |
Return on Equity (ROE) | 4.38% | 4.38% | 6.28% | 9.05% | 9.97% | -8.66% |
Return on Assets (ROA) | 3.77% | 3.77% | 5.15% | 5.16% | 4.99% | -1.83% |
Return on Invested Capital (ROIC) | 5.23% | 5.42% | 6.90% | 8.48% | 9.17% | -4.40% |
Return on Capital Employed (ROCE) | 8.90% | 8.90% | 11.80% | 12.30% | 12.60% | -5.70% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 3.86% | 4.34% | 5.42% | 5.17% | 12.42% | -12.43% |
FCF Yield | -1.59% | -1.79% | 4.23% | -3.57% | 13.42% | -16.68% |
Buyback Yield / Dilution | 0.29% | 0.29% | - | - | - | 0.01% |